Active Ingredient & Formulation
-
Contains 5 mg desloratadine, a second-generation H₁-histamine receptor antagonist.
-
Available as oral film-coated tablets or orally disintegrating tablets (Reditabs). en.wikipedia.org+15drugs.com+15medicinenet.com+15drugtodayonline.com+5sciencedirect.com+5en.wikipedia.org+5
Mechanism of Action
Desloratadine selectively and competitively blocks peripheral H₁-histamine receptors, preventing histamine-triggered symptoms without significant central nervous system penetration—hence minimal drowsiness. rxhive.zynapte.com
Indications
-
Seasonal and perennial allergic rhinitis: relieves sneezing, runny nose, itchy/watery eyes, and throat irritation
-
Chronic idiopathic urticaria (hives): reduces itching, rash, and hive size/quantity medicine.comwebmd.com+3rxhive.zynapte.com+3medicine.com+3
Dosage & Administration
-
Adults & adolescents (≥ 12 years): 5 mg once daily, with or without food
-
Children 6–11 years: 2.5 mg daily
-
Children 1–5 years: 1.25 mg daily (liquid form)
-
Infants 6–11 months: 1 mg daily johnleeindia.com+15drugs.com+15medcentral.com+15carehospitals.com+1medcentral.com+1rxhive.zynapte.commedicine.com+1rxhive.zynapte.com+1
-
Adjust dose to every-other-day in adults with significant renal or hepatic impairment. en.wikipedia.org+6medcentral.com+6rxhive.zynapte.com+6
Pharmacokinetics
-
Onset: within 1 hour; duration: up to 24 hours
-
Half-life: ~27 hours in healthy adults; extended (~33 h) in elderly
-
Absorption: peak blood level ~3 h post-dose; unaffected by food
-
Metabolism/excretion: hepatic via CYP2D6/CYP3A4 → metabolites excreted via urine and feces





Reviews
There are no reviews yet.